Blog

Enhancing clinical trials with real-world evidence in pregnancy research

Learn how real-world evidence improves clinical trials in pregnancy by enhancing safety data, trial design,…

Certara2026 年 6 月 26 日

Guide

如何采用决策优先策略构建符合最佳实践的全球价值档案

Learn how a decision-first approach to value dossier preparation helps teams build pharma value dossiers…

Certara2026 年 6 月 25 日

Poster

开发人外周血单核细胞（PBMC）TXG-MAPr 模型，作为解释人类群体中毒理动力学变异性的机制框架

Leiden University and EFSA researchers present the PBMC TXG-MAPr — a network-based transcriptomic tool mapping…

Certara2026 年 6 月 23 日

Poster

利用来自大型健康志愿者队列的外周血单核细胞，对人类毒理动力学变异性进行特征分析

Research from Leiden University and EFSA characterizing interindividual toxicodynamic variability using peripheral blood mononuclear cells…

Certara2026 年 6 月 23 日

Announcement

Certara 推出“Bio Venture Catalyst”计划，助力新兴生物科技企业降低投资风险并加速研发进程

Integrated offering combines drug development, regulatory, commercial, and investor strategy expertise to help early-stage biotech…

Danielle Pillsbury2026 年 6 月 23 日

Poster

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…

Certara2026 年 6 月 23 日

Poster

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…

Certara2026 年 6 月 23 日

Poster

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Discover how Quantitative Systems Pharmacology (QSP) was used to predict cytokine release syndrome risk and…

Certara2026 年 6 月 23 日

Poster

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Authors: Ibtissem Rebai (Certara), Stephen Duffull (Certara), Ayman Akil (Certara), Anna Largajolli (Certara), Floris Fauchet…

Certara2026 年 6 月 22 日

Poster

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

Discover how the AI/ML Special Interest Group is advancing responsible artificial intelligence in pharmacometrics through…

Certara2026 年 6 月 22 日

Certara 服务

Enhancing clinical trials with real-world evidence in pregnancy research

如何采用决策优先策略构建符合最佳实践的全球价值档案

开发人外周血单核细胞（PBMC）TXG-MAPr 模型，作为解释人类群体中毒理动力学变异性的机制框架

利用来自大型健康志愿者队列的外周血单核细胞，对人类毒理动力学变异性进行特征分析

Certara 推出“Bio Venture Catalyst”计划，助力新兴生物科技企业降低投资风险并加速研发进程

将内源性配体竞争纳入治疗性单克隆抗体的机制全身 PBPK 模型

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Machine Learning-Based Covariate Selection for Population Pharmacokinetic Modeling

Shaping the future of AI/ML in pharmacometrics through collaboration, education and best practices

订阅时事通讯

快捷链接

解决方案

联系我们